Vienna Institute for Research in Ocular Surgery Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2014
NCT02215330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Prim. Prof. Dr. Oliver Findl, MBA | Vienna Institute for Research in Ocular surgery (VIROS), Vienna, Austria